July 17, 2013

Stanton A. Glantz, PhD

Independent analyst rejects Lorillard's criticism of conclusion that menthol promotes youth smoking; supports TPSAC conclusion

Capstone, which describes itself as "a Washington, DC-based policy analysis and regulatory due diligence research firm that provides expert advice to long-term investors," has evaluated Lorillard's criticism of the FDA TPSAC analysis of menthol and concluded that Lorillard's "the criticism of their [TPSAC's] research is unwarranted." 

In particular, Capstone agreed that the conclusion that youth who initiated with menthol cigarettes are at greater risk of progression to established smoking and experience higher levels of nicotine dependence was correct.

For access to the report please contact Capstone at [email protected]      


Add new comment

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.